About the Company
resTORbio, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development and commercialization of medicines for aging-related diseases and conditions. It offers an immunotherapy under the TORC1 program. The company was founded by Chen Schor and Joan Mannick on July 5, 2016 and is headquartered in Boston, MA.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $TORC News
Adicet Bio Inc (ACET)
REDWOOD CITY, Calif. & BOSTON - Adicet Bio, Inc. (NASDAQ:ACET), a biotechnology company focusing on the development of gamma delta T cell therapies, announced today that its ...
Pitching a Column to Inc.com
Inc. welcomes column proposals from experts and thought leaders at the top of their industries. Your proposal should include: Why you will make an excellent contributor to Inc.com Topics of ...
About Inc.com | Everything You Need to Know to Grow and Start Your Business
Inc. is the voice of the American entrepreneur. We inspire, inform, and document the most fascinating people in business: the risk-takers, the innovators, and the ultra-driven go-getters that ...
Hellish Inc.
Hellish Inc. is a procedural action platformer with rogue-like mechanics focused on precise and fluid movement and player progression. Advertisement Hellish Inc. is a procedural action platformer ...
Adicet Bio Inc (ACET)
Investing.com – U.S. stocks were higher after the close on Tuesday, as gains in the Consumer Services, Technology and Industrials sectors led shares higher. At the ...
Loading the latest forecasts...